Murine model of interstitial cytomegalovirus pneumonia in syngeneic bone marrow transplantation: Persistence of protective pulmonary CD8-T-cell infiltrates after clearance of acute infection

Journal of Virology

Volumn 74, Issue 16, 2000, Pages 7496-7507

  Podlech, J ^a   Holtappels, R ^a   Pahl Seibert, M F ^a   Steffens, H P ^a   Reddehase, M J ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BONE MARROW TRANSPLANTATION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; FEMALE; HISTOPATHOLOGY; IMMUNE DEFICIENCY; INTERSTITIAL PNEUMONIA; LYMPHOCYTIC INFILTRATION; MEMORY CELL; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS REPLICATION;

ANIMALS; BONE MARROW TRANSPLANTATION; CD8-POSITIVE T-LYMPHOCYTES; CYTOMEGALOVIRUS INFECTIONS; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; LUNG; LUNG DISEASES, INTERSTITIAL; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; PHENOTYPE; PNEUMONIA, VIRAL; TRANSPLANTATION, ISOGENEIC;

EID: 0033860425     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.16.7496-7507.2000     Document Type: Article

References (56)

1. Control of cytomegalovirus in bone marrow transplantation chimeras lacking the prevailing antigen-presenting molecule in recipient tissues rests primarily on recipient-derived CD8 T cells
2. Memory T lymphocytes
3. Lungs are a major organ site of cytomegalovirus latency and recurrence
4. Cytopathology or immunopathology? The puzzle of cytomegalovirus pneumonitis revisited
5. Long-term sequelae after recovery from cytomegalovirus pneumonia in allogeneic bone marrow transplant recipients
6. Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo
7. Early reactivation of cytomegalovirus and high risk of interstitial pneumonitis following T-depleted BMT for adults with hematological malignancies
8. Requirement for CD44 in activated T cell extravasation into an inflammatory site
9. Evidence against a key role for transforming growth factor-β1 in cytomegalovirus-induced bone marrow aplasia
10. Cytomegalovirus infection following hematopoietic stem cell transplantation
11. Cytomegalovirus pneumonia after bone marrow transplantation: Risk factors and response to therapy
12. A cell surface molecule involved in organ-specific homing of lymphocytes
13. Virologic and pathogenetic aspects of cytomegalovirus infection
14. Is cytomegalovirus interstitial pneumonitis in transplant recipients an immunopathological condition?
15. Augmentation of graft-versus-host reaction by cytomegalovirus infection resulting in interstitial pneumonitis
16. In vivo/ex vivo T cell depletion for GvHD prophylaxis influences onset and course of active cytomegalovirus infection and disease after BMT
17. Epidemiology of cytomegalovirus infection
18. Cytomegaloviruses
19. Control of murine cytomegalovirus in the lungs: Relative but not absolute immunodominance of the immediate-early 1 nonapeptide during the antiviral cytolytic T-lymphocyte response in pulmonary infiltrates
20. The putative natural killer decoy early gene mO4 (gp34) of murine cytomegalovirus encodes an antigenic peptide recognized by protective antiviral CD8 T cells
21. The role of T-lymphocyte subsets in the control of cytomegalovirus infection
22. Focal transcriptional activity of murine cytomegalovirus during latency in the lungs
23. Patchwork pattern of transcriptional reactivation in the lungs indicates sequential checkpoints in the transition from murine cytomegalovirus latency to recurrence
24. Latency versus persistence or intermittent recurrences: Evidence for a latent state of murine cytomegalovirus in the lungs
25. Cytomegalovirus interstitial pneumonia in autologous bone marrow transplant recipients
26. Risk factors for cytomegalovirus infection after human marrow transplantation
27. Cytomegalovirus infection after bone marrow transplantation: An association with acute graft-v-host disease
28. Regulation of adhesion molecule expression by CD8 T cells in vivo. II. Expression of L-selectin (CD62L) by memory cytolytic T cells responding to minor histocompatibility antigens
29. Cytomegalovirus pneumonia - A consequence of immunosuppression and pre-existing lung damage rather than immunopathology?
30. Cytomegalovirus pneumonia prior to engraftment following T-cell depleted bone marrow transplantation
31. Histopathology of murine cytomegalovirus infection after MHC class-I disparate bone marrow transplantation
32. Reconstitution of CD8 T cells is essential for the prevention of multiple-organ cytomegalovirus histopathology after bone marrow transplantation
33. Cytomegalovirus pathogenesis after experimental bone marrow transplantation
34. Hierarchical and redundant lymphocyte subset control precludes cytomegalovirus replication during latent infection
35. Detection of intracytoplasmic cytokine using flow cytometry and directly conjugated anti-cytokine antibodies
36. The immunogenicity of human and routine cytomegaloviruses
37. The conditions of primary infection define the load of latent viral genome in organs and the risk of recurrent cytomegalovirus disease
38. In vivo application of recombinant interleukin 2 in the immunotherapy of established cytomegalovirus infection
39. CD8-positive T lymphocytes specific for murine cytomegalovirus immediate-early antigens mediate protective immunity
40. Interstitial murine cytomegalovirus pneumonia after irradiation: Characterization of cells that limit viral replication during established infection of the lungs
41. Cytomegalovirus infection after autologous bone marrow transplantation: Occurrence of cytomegalovirus disease and effect on engraftment
42. Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: Pattern of recovery and correlation with cytomegalovirus infection and disease
43. Pathogenesis of cytomegalovirus pneumonia in immunocompromised hosts
44. Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones
45. Cytomegalovirus pneumonia
46. Murine cytomegalovirus replication in the lungs of athymic BALB/c nude mice
47. Interstitial pneumonitis in bone marrow transplant recipients is associated with local production of TH2-type cytokines and lack of T cell-mediated cytotoxicity
48. Cytomegalovirus induces interstitial lung disease in allogeneic bone marrow transplant recipient rats independent of acute graft-versus-host response
49. Preemptive CD8 T-cell immunotherapy of acute cytomegalovirus infection prevents lethal disease, limits the burden of latent viral genomes, and reduces the risk of virus recurrence
50. Early and late interstitial pneumonia following human bone marrow transplantation
51. Murine cytomegalovirus-associated pneumonitis in the lungs free of the virus
52. Nitric oxide mediates murine cytomegalovirus-associated pneumonitis in lungs that are free of the virus
53. The selectins: Vascular adhesion molecules
54. L-Selectin-deficient mice have impaired leukocyte recruitment into inflammatory sites
55. Cytomegalovirus infection after autologous bone marrow transplantation with comparison to infection after allogeneic bone marrow transplantation
56. Epidemiology and pathogenesis of cytomegalovirus disease